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Our objective was to determine if automated peritoneal dialysis (APD) leads to changes in nutritional parameters of patients
treated by continuous ambulatory peritoneal dialysis (CAPD). Twenty-six patients (15 males; 50.5 ± 14.3 years) were evaluated
during CAPD while training for APD and after 3 and 6 months of APD. Body fat was assessed by the sum of skinfold thickness
and the other body compartments were assessed by bioelectrical impedance. During the 6-month follow-up, 12 patients gained
more than 1 kg (GW group), 8 patients lost more than 1 kg (LW group), and 6 patients maintained body weight (MW group).
Except for length on dialysis that was longer for the LW group compared with the GW group, no other differences were found
between the groups at baseline. After 6 months on APD, the LW group had a reduction in body fat (24.5 ± 7.7 vs 22.1 ± 7.3 kg;
P = 0.01), body cell mass (22.6 ± 6.2 vs 21.6 ± 5.8 kg, P = 0.02) and phase angle (5.4 ± 0.9 vs 5.1 ± 0.8 degrees, P = 0.004). In
the GW group, body fat (25 ± 7.6 vs 27.2 ± 7.6 kg, P = 0.001) and body cell mass (20.1 ± 3.9 vs 20.8 ± 4.0 kg, P = 0.05) were
increased. In the present study, different patterns of change in body composition were found. The length of previous dialysis
treatment seems to be the most important factor in determining these nutritional modifications.
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Introduction
In the past decade, many patients on continuous am-
bulatory peritoneal dialysis (CAPD) have been switched to
automated peritoneal dialysis (APD) (1). APD offers impor-
tant advantages over CAPD and has become the first
choice for many patients. The potential improvement in the
quality of life is one of the most important advantages of
this method (2). In fact, APD can greatly reduce the time
the patient dedicates daily to his/her treatment, providing
more free time for leisure activities and for work (3). Al-
though still controversial, the incidence of peritonitis seems
to be lower in APD compared to CAPD probably as the
result of reduction of the number of connections needed for
treatment (4). Additionally, APD might benefit high trans-
porter patients due to the higher exchange frequencies
with shorter dwell times (5).
On the other hand, APD has some disadvantages.
Some studies have observed a faster decline in the re-
sidual renal function in patients on APD (6). This could, in
turn, contribute to the development of anemia (7), inflam-
mation (8,9), malnutrition (10,11), and increase the mortal-
ity risk (12,13). Moreover, a greater volume of dialysis fluid
is used in APD and hence, a larger glucose load is offered,
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which may have harmful effects on the peritoneal mem-
brane as time on peritoneal dialysis advances (14). If
glucose absorption increases, a number of glucose-re-
lated metabolic derangements such as hyperinsulinemia,
dyslipidemia and obesity may also occur (15,16). In addi-
tion, APD may not be the best choice for low transporter
patients who can benefit with therapy with long dwells (1).
Thus, taking into account these modality-related factors,
APD has advantages and disadvantages that can affect
the nutritional condition of the patients.
Using nutritional markers, such as body weight, body
mass index, serum albumin, and protein equivalent of
nitrogen appearance (PNA), only 3 studies have com-
pared the nutritional condition of patients on CAPD with
those on APD and have reported no differences between
the two modalities (17-19). However, none of these studies
analyzed prospectively the effects of APD on nutritional
parameters. Thus, the present study evaluated whether
APD could lead to changes in the nutritional status and
body composition of patients previously treated by CAPD.
Patients and Methods
Patients
This study enrolled 26 patients on APD (15 males) from
the Dialysis Unit of the Federal University of São Paulo and
Oswaldo Ramos Foundation who had been on CAPD.
Only patients older than 18 years of age who were on
CAPD for at least 3 months and were free of peritonitis for
3 months were included in the study prior to the start of
APD. Their mean age was 50.5 ± 14.3 years, body mass
index was 26.6 ± 4.9 kg/m2, 17 patients (70.8%) had
residual renal function (creatinine clearance = 4.4 ± 5.6
mL/min) and the median length of time on CAPD was 11
months (range: 3–60 months). The main causes of chronic
kidney disease were diabetes mellitus for 9 patients (34.6%),
hypertensive nephrosclerosis for 5 patients (19.2%), and
chronic glomerulonephritis for 2 patients (7.7%). The cause
of chronic kidney disease was not determined for 10 (38.5%)
patients. Overall, 10 patients (38.5%) had diabetes melli-
tus.
All patients were dialyzed using conventional glucose-
based peritoneal dialysis solutions (1.5, 2.5, and 4.25%).
When patients were on CAPD, the majority of them (76.9%,
N = 20) were doing 4 exchanges per day, with each bag
containing 2.0 to 2.5 L. When the patients were transferred
to APD, 57.7% (N = 15) of them were on continuous cyclic
peritoneal dialysis with 1 or 2 additional exchanges during
the day with bags of 2.0 to 2.5 L. The remaining patients
(42.3%, N = 11) were on nightly intermittent peritoneal
dialysis with an empty peritoneal cavity during the daytime.
The patients were classified as low (N = 1, 3.8%), low
average (N = 8, 30.9%), high average (N = 14, 53.8%), and
high (N = 3, 11.5%) transporters.
This study was approved by the Human Investigation
Review Committee of the Federal University of São Paulo
and written informed consent was obtained from each
subject.
Methods
Study protocol. This was a prospective study that in-
cluded patients on CAPD who were evaluated shortly
before the start of APD and after 3 and 6 months on APD.
All participants were initially submitted to a first interview in
order to meet the inclusion criteria, and to obtain informed
consent. Their nutritional status, body composition and
biochemical parameters were assessed during CAPD,
and 3 and 6 months after the beginning of APD.
Nutritional assessment. Nutritional assessment in-
cluded anthropometric measurements (body weight, height,
triceps skinfold thickness, midarm circumference, and body
mass index) and PNA, determined using 24-h urinary and
dialysate urea, according to National Kidney Foundation–
DOQI recommendations (20).
Body composition. Body fat was estimated by the sum
of skinfold thickness measured at four sites (biceps, tri-
ceps, subscapular, and suprailiac). The measurements
were performed using the Lange® skinfold caliper (Cam-
bridge Instrument, USA). Body density was calculated
using the formula of Durnin and Womersley (21) and the
percentage of body fat was then calculated by Siri’s equa-
tion (22). Lean body mass, total body water, intracellular
and extracellular body water, phase angle, and body cell
mass were evaluated by bioelectrical impedance (BIA),
using a single frequency tetrapolar technique (800A, 50
kHz, model BIA 101 Quantum, RJL Systems, USA). The
Fluids & Nutrition software (version 3.0) was used to calcu-
late the body composition compartments.
All anthropometric and BIA measurements were per-
formed while the patients were with an empty peritoneal
cavity and after a careful physical examination to assure
that the patients were free of edema.
Biochemical data. Blood samples were drawn after an
overnight fast of 12 h. Serum albumin (normal range: 3.4 to
4.8 g/dL) was measured by the bromocresol green meth-
od. Serum and dialysate creatinine, urea and glucose were
determined by a standard autoanalyzer. The peritoneal
glucose absorption was calculated as the difference be-
tween the amount of glucose provided by the dialysis fluid
and the amount of glucose drained into the dialysate.
Total weekly Kt/V urea and creatinine clearance were
calculated using standard methods (23).
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Statistical analysis
Data are reported as means ± standard deviation for
normally distributed variables and as median and ranges
for skewed variables not normally distributed. One-way
repeated measures analysis (ANOVA) was used to assess
changes in laboratory, dialysis and nutritional parameters
during follow-up (baseline, 3 and 6 months). Paired Stu-
dent t-test was used to compare the nutritional, laboratory
and dialysis parameters between baseline and 6 months in
the three groups according to the changes in body weight
(gained weight, lost weight and maintained weight). Chi-
square test or Fisher exact test was used for categorical
variable comparison between groups. Differences with P
values ≤ 0.05 were considered to be statistically signifi-
cant. Statistical analysis was performed with the SPSS
software (version 11.0; SPSS, Inc., USA).
Results
The laboratory, dialysis, body composition, and nutri-
tional parameters of patients at baseline and during follow-
up are reported in Table 1. A reduction of serum urea and
glucose was observed after 6 months on APD. Instilled and
drained glucose increased significantly, although no change
was seen in absorbed glucose. No other statistically sig-
nificant changes were found either in the dialysis param-
eters or in the nutritional and body composition measure-
ments after 6 months on APD. Although body weight did
not change significantly during follow-up, 12 patients
(46.1%) gained more than 1 kg [median (range); GW
group: 2.1 kg (1.0 to 7.7 kg)], 8 patients (30.8%) lost more
than 1 kg [LW group: -3.2 kg (-6.8 to -1.6 kg)] and 6 patients
(23.1%) maintained their body weight [MW group: 0.3 kg
Table 1. Laboratory, dialysis, body composition, and nutritional parameters during the follow-up of patients who were on continuous
ambulatory peritoneal dialysis (CAPD) and were switched to automated peritoneal dialysis (APD).
CAPD APD (3 months) APD (6 months) P
Laboratory parameters
Serum creatinine (mg/dL) 8.7 ± 3.9 8.7 ± 3.1 8.7 ± 3.2
Serum urea (mg/dL) 105.9 ± 27.0 92.5 ± 27.2 92.7 ± 25.9 0.03*
Serum glucose (mg/dL)a 172.6 ± 82.8 121.8 ± 60.1 137.4 ± 75.8 0.01*
Dialysis parameters
Dialysate glucose (g/day) 172.6 ± 28.8 266.8 ± 77.6 279.2 ± 73.1 0.001*
Drained glucose (g/day)b 62.2 ± 24.9 128.2 ± 38.9 137.3 ± 53.4 0.001*
Absorbed glucose (g/day)b 112.1 ± 28.9 132.7 ± 54.7 135.9 ± 60.3
Kt/V urea (weekly)b
Total 2.50 ± 0.79 2.46 ± 0.80 2.41 ± 0.68
Peritoneal 1.81 ± 0.41 1.92 ± 0.61 1.91 ± 0.50
Renal 0.69 ± 0.74 0.54 ± 0.56 0.50 ± 0.53
Residual renal function (CrCl mL/min)c 4.4 ± 5.6 3.5 ± 4.1 3.2 ± 4.3
Body composition and nutritional parameters
Weight (kg) 69.5 ± 11.0 69.5 ± 10.5 69.8 ± 11.4
Body mass index (kg/m2) 26.6 ± 4.9 27.0 ± 5.0 26.7 ± 5.4
MAMC (cm) 23.5 ± 3.2 23.9 ± 3.1 23.9 ± 3.9
Lean body mass (kg) 48.9 ± 10.7 48.2 ± 10.1 48.3 ± 10.0
Body fat (kg)b 23.7 ± 7.2 24.0 ± 7.6 24.4 ± 7.4
Total body water (L) 36.8 ± 7.0 36.0 ± 6.6 36.1 ± 6.4
Intracellular water (L) 9.4 ± 4.7 19.2 ± 4.7 19.4 ± 4.4
Extracellular water (L) 17.4 ± 2.9 16.9 ± 2.7 16.7 ± 2.8
Body cell mass (kg) 21.3 ± 5.2 21.0 ± 5.2 21.3 ± 4.8
Phase angle (degrees) 5.2 ± 1.0 5.1 ± 1.2 5.4 ± 1.1
PNA (g·kg-1·day-1)d 0.70 ± 0.09 0.68 ± 0.14 0.66 ± 0.14
Serum albumin (g/dL)e 3.7 ± 0.6 4.0 ± 1.0 3.8 ± 0.6
Data are reported as means ± standard deviation for N = 26, except for aN = 13; bN = 23; cN = 17; dN = 22; eN = 16. CrCl = creatinine
clearance. MAMC = midarm muscle circumference. PNA = protein equivalent of nitrogen appearance. Phase angle = relation between
the direct measures of resistance and reactance (phase angle = arc-tangent reactance/resistance x 180°/π) (32). Kt/V = measure of
the amount of plasma cleared of urea multiplied by time (K x t) divided by the urea distribution volume (V). Data were analyzed
statistically by one-way repeated measures analysis (ANOVA). *Significant differences refer to CAPD compared to 6 months APD. No
significant differences were found compared to 3 months APD.
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(-0.4 to 0.9 kg)] after 6 months on APD. In view of the large
differences in the body weight changes, statistical analysis
was carried out comparing these groups. No differences
were observed among the 3 groups in relation to the
characteristics of membrane transport, number of patients
on continuous cyclic peritoneal dialysis and nightly inter-
mittent peritoneal dialysis, and demographic and dialysis
parameters before APD was initiated (data not shown).
The percentage of diabetic patients in each group was also
similar (GW group: 41.7% vs LW group: 37.5% vs MW
group: 33.3%; P = 0.94). When the baseline factors that
could influence the changes in body weight were com-
pared between the GW and LW groups, no differences
were found except for the length of CAPD that was signifi-
cantly longer in the group that lost weight [median (range);
GW group: 10 months (3-21 months) vs LW group: 17
months (10-46 months); P = 0.01].
As shown in Tables 2 and 3, no differences were
Table 2. Body composition and nutritional parameters according to the changes of body weight during the follow-up of patients who
were on continuous ambulatory peritoneal dialysis (CAPD) and were switched to automated peritoneal dialysis (APD) (N = 26).
Body composition and Gained weight (N = 12) Lost weight (N = 8) Maintained weight (N = 6)
nutritional parameters
CAPD APD P CAPD APD P CAPD APD P
(6 months) (6 months) (6 months)
Weight (kg) 69.4±10.7 72.3±11.2 70.1±14.1 66.4±13.7 69.0±8.5 69.3±8.3
MAMC (cm) 23.2±3.8 23.7±4.9 23.9±2.7 23.8±2.6 24.2±2.7 24.7±2.5
Lean body mass (kg) 46.5±9.0 47.4±8.2 50.6±13.0 49.1±12.6 53.1±11.2 50.7±11.1 0.01*
Body fat (kg) 25.0±7.6 27.2±7.6 0.001* 24.5±7.7 22.1±7.3 0.01* 19.5±5.2 20.8±5.4
Total body water (L) 35.4±5.6 35.8±5.2 38.1±8.8 36.6±8.5 39.0±7.3 36.8±6.9 0.01*
Intracellular water (L) 18.6±3.5 19.0±3.6 0.04* 20.7±5.7 19.7±5.3 0.02* 21.2±5.9 20.8±5.3
Extracellular water (L) 17.0±2.8 16.8±2.6 17.4±3.6 16.9±3.5 17.8±2.3 16.0±2.5 0.04*
Body cell mass (kg) 20.1±3.9 20.8±4.0 0.05* 22.6±6.2 21.6±5.8 0.02* 23.3±6.5 22.8±5.8
Phase angle (degrees) 5.2±1.1 5.4±1.2 5.4±0.9 5.1±0.8 0.004* 4.9±1.1 5.5±1.3
PNA (g·kg-1·day-1) 0.71±0.09 0.71±0.11 0.74±0.07 0.54±0.06 0.001* 0.63±0.10 0.70±0.19
Serum albumin (g/dL) 3.7±0.5 3.7±0.3a 3.7±0.6 3.6±0.8 3.5±0.7 3.9±0.7
Data are reported as means ± standard deviation for N = 26, except aN = 7. MAMC = midarm muscle circumference. PNA = protein
equivalent of nitrogen appearance. Phase angle = relation between the direct measures of resistance and reactance (phase angle =
arc-tangent reactance/resistance x 180°/p) (32). Data were analyzed statistically by the paired Student t-test. *CAPD vs APD (6
months).
Table 3. Laboratory and dialysis parameters according to the changes of body weight during the follow-up of patients who were on
continuous ambulatory peritoneal dialysis (CAPD) and were switched to automated peritoneal dialysis (APD).
Gained weight (N = 12) Lost weight (N = 8) Maintained weight (N = 6)
CAPD APD P CAPD APD P CAPD APD P
(6 months) (6 months) (6 months)
Laboratory parameters
Serum creatinine (mg/dL) 7.5±3.2 8.2±2.3 10.9±4.6 9.4±3.4 7.8±3.3 9.2±4.7
Serum urea (mg/dL) 95.3±20.9 99.3±20.5 119.5±32.7 73.9±20.5 0.004* 109.2±29.5 104.3±31.5
Dialysis parameters
Dialysate glucose (g/day) 163.8±36.5 261.5±55.7 <0.001* 178.4±18.7 280.3±86.9 0.008* 182.5±19.4 313.3±84.8 0.02*
Drained glucose (g/day) 70.9±20.0 126.5±51.9 0.01* 59.6±30.8 138.1±44.8 0.009* 46.6±21.6 159.8±70.8 0.02*
Absorbed glucose (g/day) 97.8±24.6 136.9±55.1 116.4±31 128.7±56.3 137.4±15.1 143.7±86.5
Kt/V urea (weekly)
Total 2.54±0.74 2.55±0.77 2.46±0.98 2.37±0.72 2.49±0.77 2.16±0.41
Peritoneal 1.79±0.40 1.97±0.38 1.93±0.44 2.03±0.59 1.68±0.43 1.62±0.58
Renal 0.75±0.82 0.59±0.69 0.52±0.67 0.34±0.40 0.81±0.75 0.54±0.31
Data are reported as means ± standard deviation for N = 26. Kt/V = measure of the amount of plasma cleared of urea multiplied by
time (K x t) divided by the urea distribution volume (V). Data were analyzed statistically by the paired Student t-test. *CAPD vs APD (6
months).
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observed among the groups regarding body composition,
nutritional and laboratory parameters at baseline. When
comparing the body composition and nutritional param-
eters during the follow-up (Table 2), the patients who
gained body weight increased significantly body fat (2.2 ±
1.5 kg), intracellular water (0.7 ± 1.0 L) and body cell mass
(0.7 ± 1.1 kg), while those patients who lost body weight
reduced significantly body fat (-2.3 ± 1.7 kg), intracellular
water (-1.0 ± 0.8 L), body cell mass (-1.1 ± 0.9 kg) and
phase angle (-0.3 ± 0.2). The group of patients who main-
tained body weight had a significant decrease in lean body
mass (-2.4 ± 1.4 kg), and total (-2.2 ± 1.5 L) and extracel-
lular body water (-1.8 ± 1.6 kg). In addition, a tendency to
increased body fat (1.3 ± 1.4 kg) and serum albumin (0.4 ±
0.4 g/dL) was observed in this group. The protein intake
estimated by PNA was reduced only in the group that lost
body weight.
As can be seen in Table 3, a reduction of serum urea
was observed in the group that lost body weight. The
amount of instilled glucose and drained glucose was higher
in all groups after 6 months, but only patients who gained
body weight had a tendency to higher glucose absorption.
Discussion
In the present study, we determined whether APD
leads to changes in the nutritional status and body compo-
sition parameters in patients previously treated by CAPD.
Overall, no significant changes were observed. However,
in a detailed analysis, we observed that the majority of the
patients (77%) had increased or decreased body weight in
the 6-month follow-up period. Thus, we performed the
analysis by dividing the patients into groups according to
changes in body weight. In fact, using this approach, we
found different patterns of changes in the body compart-
ments, according to the changes in body weight. The
different patterns observed were not associated with de-
mographics, nutritional, biochemical, or dialytic character-
istics at CAPD, except for time on CAPD that was signifi-
cantly shorter in the patients who gained body weight
compared with those who lost body weight. Regardless of
the peritoneal dialysis modality, the relationship between
length of time on peritoneal dialysis and changes in body
compartments, especially body fat compartment, has al-
ready been shown. The majority of the studies showed that
whereas lean body mass seems to be rather stable, body
fat and body weight increase considerably in a short time
on peritoneal dialysis (24-26). On the other hand, Davies et
al. (27) reported that following an initial improvement of
body weight and mid-arm circumference, a decline may
occur after 2 years of peritoneal dialysis. Indeed, several
studies suggest that during long-term peritoneal dialysis a
gradual deterioration in nutritional status may occur with a
decrease in lean body mass (25,27). It is of note that none
of these studies analyzed whether the peritoneal dialysis
modality, CAPD or APD, could be associated with changes
of body weight.
When a detailed analysis of changes in body compart-
ments was performed in our study, we observed that the
group that gained body weight showed no significant
changes in total body water and lean body mass, while
body cell mass (BCM) and body fat increased significantly.
It is generally assumed that the accumulation of body fat is
related to the glucose absorption from the dialysate. Par-
ticularly in APD, a larger amount of glucose is offered as a
consequence of a greater dialysate volume used. In fact, in
our study the amount of glucose offered was in mean 65%
higher with APD compared to CAPD in the whole group of
patients. However, the drained glucose also increased,
probably due to the greater number of exchanges with
shorter dwell times. As a result, the absorbed glucose did
not change when the whole sample was considered, but in
the group of patients that gained body weight a tendency of
higher glucose absorption was found. This finding could
explain, at least in part, the accumulation of body fat in this
group. An increase in food intake could also be associated
with body fat accumulation; however, this seems not to be
the case in our study since protein intake estimated by
PNA, a surrogate marker of food consumption, did not
change in this group.
In the group of patients who lost body weight, the
decrease in body fat was accompanied by a significant
reduction in BCM, phase angle and intracellular water.
Using total body potassium method, Johansson et al. (25)
found similar results regarding BCM during the second and
third year of peritoneal dialysis. BCM is a marker for
combined somatic and visceral protein stores and is con-
sidered the most metabolically active body compartment
that is highly sensitive to changes in muscle mass (25,28).
Therefore, the reduction in BCM could indicate a reduction
of protein stores of these patients, even though no changes
in lean body mass were observed. The quantification of
BCM is difficult because reliable methods such as neutron
activation analysis or total body potassium are costly and
not widely available. In our study, BIA was the method
used to estimate BCM. The strong correlation between
BCM assessed by BIA with reference methods has already
been demonstrated in dialysis patients (28).
The reasons for the reduction in body fat and BCM
cannot be fully elucidated in this study. Factors widely
recognized to worsen nutritional status such as decline of
residual renal function and Kt/V urea did not change in
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these patients. Only the longer time on peritoneal dialysis
and the reduction of protein intake could explain the reduc-
tion of body compartments in this group. However, we
cannot exclude the possible role of other factors not ana-
lyzed in the present study such as infections, chronic
inflammation, other co-morbid conditions, and protein loss
into the dialysate. The reduction in BCM was accompanied
by a reduction of phase angle, which has been pointed out
as an indicator of cell membrane integrity. Previous stud-
ies reported that low phase angle was associated with
increased mortality in hemodialysis patients (29), with
lower indexes of nutritional status (29,30) and with lower
BCM and intracellular water in hemodialysis and perito-
neal dialysis patients (31). Therefore, the reduction of
BCM and phase angle might be a sign of worse prognosis
for the patients who lost body weight.
In spite of the small number of patients in the group that
maintained body weight, it is important to note that after 6
months on APD, changes in body compartments were
diverse as compared with those patients who gained or
lost body weight. Body water was the compartment that
suffered modifications the most in these patients. A signifi-
cant reduction in extracellular water occurred and as a
consequence, total body water and lean body mass also
decreased associated with increased serum albumin. As 5
of 6 patients in this group were high or high average
transporters, we can speculate that this might explain the
reduction of body water when they were switched to APD.
The lack of a control group constituted by patients
followed on CAPD makes it difficult to affirm whether the
changes occurred as a consequence of APD or were the
result of the peritoneal dialysis per se. In addition, since
our sample was constituted by patients undergoing dialy-
sis for different periods of time, we can not distinguish the
contribution of peritoneal dialysis modality or dialysis vin-
tage on the modification found.
This study provides evidence that patients initiating
APD may have different patterns of change in body com-
partments, which seems to be dependent on the previous
duration of CAPD. Moreover, it is of note that simple
nutritional assessment methods, such as anthropometry
and BIA, were able to detect these modifications.
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